W

Wave Life Sciences Tech Stack

RNA medicine platform spanning editing, splicing, and antisense therapeutics

Biotechnology Research Cambridge, Massachusetts 201–500 employees Founded 2012 Public Company

Wave Life Sciences is a public biotech company developing RNA therapeutics across four clinical programs (Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington's disease, obesity) plus preclinical candidates. The tech stack reveals a hybrid biotech operations model: analytical (R, Python, Shiny, Streamlit, SAMtools, LC-MS, HPLC) paired with regulatory infrastructure (Veeva, SonarQube, compliance tooling), but active projects signal scaling friction—zero-trust security hardening, crowdstrike automation, bioinformatics dataset scalability, and cGMP control system upgrades all indicate growing internal complexity as the pipeline expands.

Tech Stack 21 technologies

Core StackCrowdStrike Python Docker MySQL SonarQube Veeva HPLC Freshservice Windows R Shiny Streamlit Git SAMtools Excel LC-MS Word Microsoft Access Outlook PowerPoint Microsoft Project

What Wave Life Sciences Is Building

◆Challenges

Training compliance management
Training program improvement
Vendor qualification process
Compliance with regulatory standards
Scalability of large bioinformatics datasets
High-performance compute environments
Streamlining data-driven operations
Automation reliability improvement
Cgmp control system modifications
Equipment upgrade projects

▲Active Projects

Clinical development of cardiometabolic programs
Lms upgrades
Investigator brochures
Vendor management program
Internal audit program
Zero trust strategy implementation
Crowdstrike telemetry and automation
Vulnerability scanning and remediation dashboards
Quality management review content development
Development of oligonucleotide therapeutics tools

Hiring Activity

Accelerating20 roles · 10 in 30d

Department

Engineering

4

Healthcare

2

Manufacturing

2

Ops

2

Research

2

Executive

1

Finance

1

Legal

1

Seniority

Intern

10

Director

4

Senior

3

Manager

2

Junior

1

VP

1

Company intelligence

Find more companies like Wave Life Sciences by tech stack, pain points and active projects

Get started free

About Wave Life Sciences

Wave Life Sciences operates a diversified RNA therapeutics platform called PRISM®, combining multiple chemical modalities (RNA editing, splicing, RNA interference, antisense) with human genetics to target rare and common disorders. The company is headquartered in Cambridge, Massachusetts, and employs 201–500 staff. Current hiring spans engineering, manufacturing, research, and regulatory functions across the United States and United Kingdom, with notable velocity in intern-level and director-level roles. Active work includes clinical development of cardiometabolic programs, vendor management standardization, and internal audit and quality systems—typical of a mid-stage biotech scaling from discovery toward multi-program clinical execution.

HeadquartersCambridge, Massachusetts

Company Size201–500 employees

Founded2012

Hiring MarketsUnited States, United Kingdom

Frequently Asked Questions

What technologies does Wave Life Sciences use in drug development?

R, Python, Shiny, Streamlit for data analysis and visualization; SAMtools, LC-MS, HPLC for molecular work; Veeva for regulatory management; SonarQube for code quality; Docker and Git for development infrastructure.

What clinical programs is Wave Life Sciences developing?

Four clinical programs: Alpha-1 antitrypsin deficiency, Duchenne muscular dystrophy, Huntington's disease, and obesity. Several preclinical programs utilize the broader RNA therapeutics toolkit.